Quick Answer
BOSTON SCIENTIFIC CORP reported Total Revenue of $20.07 billion for the year ending 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +19.9% in Total Revenue from 2024 to 2025.
- This data is from BOSTON SCIENTIFIC CORP's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $2.26 billion | Q3 2017: $2.22 billion | Q1 2018: $2.38 billion | Q2 2018: $2.49 billion | Q3 2018: $2.39 billion | Q1 2019: $2.49 billion | Q2 2019: $2.63 billion | Q3 2019: $2.71 billion | Q1 2020: $2.54 billion | Q2 2020: $2.00 billion | Q3 2020: $2.66 billion | Q1 2021: $2.75 billion | Q2 2021: $3.08 billion | Q3 2021: $2.93 billion | Q1 2022: $3.03 billion | Q2 2022: $3.24 billion | Q3 2022: $3.17 billion | Q1 2023: $3.39 billion | Q2 2023: $3.60 billion | Q3 2023: $3.53 billion | Q1 2024: $3.86 billion | Q2 2024: $4.12 billion | Q3 2024: $4.21 billion | Q1 2025: $4.66 billion | Q2 2025: $5.06 billion | Q3 2025: $5.07 billion.
- Over the full 10 years of available data (2016 to 2025), BOSTON SCIENTIFIC CORP's Total Revenue has grown by 139.4%.
- Historical annual values: Fiscal year 2025: $20.07 billion | Fiscal year 2024: $16.75 billion | Fiscal year 2023: $14.24 billion | Fiscal year 2022: $12.68 billion | Fiscal year 2021: $11.89 billion | Fiscal year 2020: $9.91 billion | Fiscal year 2019: $10.74 billion | Fiscal year 2018: $9.82 billion | Fiscal year 2017: $9.05 billion | Fiscal year 2016: $8.39 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: